(2), 99-115 -Inhibiting effects of hypertonic glucose and amino-acids on pancreatic exocrine function were studied using mongrel dogs with chronic gastric and pancreatic fistulae. Under the basal stimulation with secretin and pancreozymin, 20% glucose, 30% glucose and 12% amino acids were given intravenously. Infusion of these substances caused the maximal decreases in pancreatic juice volume and amylase output, to 23% and 11%, respectively (20% glucose), 32% and 29% (30% glucose), and 53% and 42% (12% amino acids). But no significant changes were noted in bicarbonate concentration. When glucose was infused, the rise in levels of blood sugar and IRI was associated with the inhibition of pancreatic exocrine secretion. Aminoacid infusion produced the greatest inhibitory effect on the pancreatic secretion and markedly elevated both the levels of IRI and IRG. Intravenous infusion of glucagon suppressed notably the exocrine function of the pancreas. glucose; amino acid; pancreatic exocrine function; hyperalimentation; glucagon Parenteral hyperalimentation, since first reported by Dudrick et al. (1968), has been widely used in clinical cases. It has been particularly favored in treating patients with diseases of the digestive tract including dehiscence and fistula due to malnutrition.
Parenteral hyperalimentation, since first reported by Dudrick et al. (1968) , has been widely used in clinical cases. It has been particularly favored in treating patients with diseases of the digestive tract including dehiscence and fistula due to malnutrition.
Hyperalimentation is also favorable for patients with acute pancreatitis, which shows a persistent high mortality. As its pathogenesis is yet extremely obscure, not allowing of any justifiable therapy, acute pancreatitis has been treated usually by keeping the pancreas at a full rest. For this purpose, the patients are forced to abstain from food and to receive gastric sucking with the expectation that pancreatic secretion caused by endogenous secretin in lowered. Parenteral hyper alimentation is beneficial to these patients since nutrition can be supplied by it without stimulating secretion of endogenous secretin.
It has recently been pointed out that parenteral hyperalimentation has another positive effect of inhibiting pancreatic exocrine secretion. In a clinical study (Oudrick et al. 1970) , it was found that hyperalimentation applied to patients with traumatic pancreatic fistula resulted in a decrease in secretion of pancreatic juice, which promoted a cure of the patients. In the present study, we conducted a series of experiments on mongrel dogs with chronic gastric and pancreatic fistulae to obtain pertinent results helpful for further understanding of the inhibiting effect and mechanism of hyperalimentation on pancreatic exocrine secretion.
MATERIALS AND METHODS
In 10 adult mongrel dogs weighing 10-20 kg, the accessory pancreatic duct was ligated and cut off, and Thomas' cannula (Thomas 1941) was inserted into the duodenum at the portion opposite to the main pancreatic duct to collect pancreatic juice. Another cannula was set in the anterior wall of the stomach to draw out the gastric juice. After a 3-week recovery, each dog was fasted for a period of 18 hr and then the gastric fistula was kept open under no anesthesia.
The pancreatic fistula was then opened, and a thin polyethylene cannula was inserted into the pancreatic duct to collect pancreatic juice. With 9 other adult dogs 7-15 kg in body weight under intravenous thiopental anesthesia, the accessory pancreatic duct was ligated, and drew out pancreatic juice through a cannula inserted into the main duct. Portal vein blood was sampled through a tube inserted from the mesenteric vessel to the portal vein.
In order to observe changes in pancreatic exocrine secretion, secretin and pancreozymin were continuously infused intravenously in a dose of 0.025 U/kg/min for conscious dogs, and 0.05 U/kg/min for anesthetized animals. Pancreatic juice was collected for 10 min periods, and the volume, amylase output and bicarbonate concentration were measured. Venous blood samples were obtained for 20 min periods and the values of blood sugar, immunoreactive insulin (IRI) and immunoreactive glucagon (IRG) were determined.
In dogs with chronic pancreatic fistula, when the volume of secreted pancreatic juice attained a plateau 50-60 min after secretin and pancreozymin infusion, the following loading tests were performed: (Before and after the loading, a solution of 0.9% saline was infused into the dog at a rate of 40 ml/hr) In anesthetized dogs, after the volume of secreted pancreatic juice attained a plateau 50-60 min following the initiation of secretin and pancreozymin infusion, solutions of 20% glucose, 30% glucose and 12% amino acids were intravenously infused at a rate of 200 ml/hr for 1 hr. Before and after each infusion, 0.9% saline solution was injected at a rate of 40 ml/hr.
With the collected pancreatic juice, after its volume was measured, amylase activity was determined by the use of Caraway's electric photometer (Caraway 1959) , enzyme proteins by Lowry's method (Lowry et al. 1951) and bicarbonate concentration by Van Slyke's method (Van Slyke et al. 1919) . For the determination of blood sugar level was used the 0-toluidine method (Glucose Test Wako). IRI was determined by the solid phase antibody method (Phadebas Insulin Test Kit, Pharmacia Co.) , and IRG by the double antibody method. Secretin and pancreozymin were obtained from Boots Co. (Haper unit), and glucagon from Novo Co. (Copenhagen). The solutions of 20% glucose and 30% glucose were prepared by the Drug Department, Tohoku University Hospital, and for the solution of 12% amino acids was used proteamin 12 (Tanabe Phar. Co.).
In each group of animals, individual differences were so great in pancreatic juice volume and amylase output that their measurements were expressed as percentage of the mean of the values of 2-3 fragments before infusion. Changes in pancreatic exocrine secretion were studied in conscious dogs after the infusion of 20% glucose, 30% glucose, 12% amino acids and 0 .9% saline solu tion performed at a rate of 200 ml/hr for 1 hr. The infusion effect of 12% amino acids at a rate of 200 ml/hr for 2 hr was also studied. The glucagon loading test was performed.
Effects of 20% glucose, 30% glucose and 12% amino acids on pancreatic exocrine secretion. Effect of 0.9% saline solution on pancreatic exocrine secretion.
As shown in Fig. 5 , the test of infusion of a 0.9% saline solution was performed 4 times in 3 dogs, but no significant changes occurred in pancreatic juice volume 
Effects of different solutions on pancreatic exocrine secretion in anesthetized dogs
In 9 anesthetized dogs, under a continuous infusion of secretin and pancreozy min at a rate of 0.05 U/kg/min, solutions of 20% glucose, 30% glucose, and 12% amino acids were prepared at a rate of 200 ml/hr for 1 hr. The resulting changes in pancreatic exocrine secretion are shown in Tables 2, 3 and 4. The inhibitory effects of the loadings on pancreatic exocrine secretion fluctuated considerably, and there was no distinctive difference in effect with different substances. Few cases showed recovery after discontinuation of the infusion. However, in No. 18171 dog, showing an inhibitory effect similar to that of conscious dogs, the volume of pancreatic juice was reduced to 62% of the initial level, and amylase output to 27%; but there was no appreciable change in bicarbonate concentration. Changes in values of IRI and IRG with infusion of different solutions In the same arrangement as was in the case of IRI, blood was sampled from the portal vein in anesthetized dogs to observe changes in IRG at an interval of 20 min for a period up to 120 min after infusion of 20% glucose, 30% glucose and 12% amino acids. The results shown in Fig. 12 indicate an increase in level of IRG only with 12% amino acids but no trend of increase at all either with 20% glucose or with 30% glucose.
DISCUSSION
In experimental studies on pancreatic exocrine secretion, the method of Thomas (Thomas 1941) collecting pancreatic juice through a cannula from duodenal fistula has been used as an established procedure in many experiments with conscious dogs. Gur Ben-Ari et al. (1969) reported that the suppressive effect on pancreatic exocrine secretion, i.e., on pancreatic juice volume and amylase output, was generally greater in the anesthetized dog than in the conscious. In the present series, we could not obtain satisfactory results with intravenously anesthetized dogs, because of the anesthetic suppression of pancreatic secretory function and the difficulty in keeping constant depth of anesthesia, both making impossible a constant collection of the required amount of pancreatic juice for a certain period. By contrast, in conscious dogs, a constant amount of pancreatic juice, 10-20 ml/10 min, could be obtained for 50-60 min after injection of secretin and pancreozymin, allowing possible assessment of changes in volume with different substance infusions.
Since Dudrick et al. (1968) reported a procedure of hyperalimentation through intravenous cannulation, its use has been highly appreciated for a long time for its possible supply of sufficient calories by way of a parenteral instead of oral intake, with beneficial maintenance of nitrogen balance and increases in body weight. The mainstay of infusion substances in hyperalimentation includes, beside fat emulsions, glucose and amino acid solutions as we used in the present experiments (20% glucose, 30% glucose, and 12% amino acids). In the present series, we used in dogs an infusion rate of 200 ml/hr, equivalent to 10-20 ml/kg/hr. This represents a rate several times greater than around 2.5 ml/kg/hr clinically used for hyperalimentation in adults. Nevertheless, there were no alteration in substances or their concentration rates. With the aim of changes in pancreatic exocrine secretion at hyperalimentation, we employed those substance solutions and their concentrations that are routinely used clinically. Among previous clinical and experimental reports on changes in pancreatic exocrine secretion after intravenous infusion of various substance solutions, Thomas and Ross (1948) observed that fasting and infusions of glucose and amino-acid solutions in patients with postoperative pancreatic fistula led to a decreased leak of pancreatic juice. Dudrick et al. (1970) also recognized effectiveness of hyperalimen tation in the treatment of traumatic pancreaticoduodenal fistula. These authors both felt that the healing of trauma with improved nutrition by parenteral highcalorie intakes, as well as a rest of the pancreas by fasting-caused suppression of the secretion of endogenous secretin and pancreozymin, was greatly contributory to the closure of a pancreatic fistula. Zajtchuk et al. (1969) also reported evident decreases in pancreatic juice volume and amylase output after hypertonic glucose infusion at hyperalimentation in patients bearing traumatic pancreatic fistula. Towne et al. (1973) and Hamilton et al. (1971) , noting suppressive effects of hyperalimentary infusions of substances on upper gastrointestinal tract secretions in dogs, specifically reported that infusions of 20% glucose and 5% amino-acid solutions suppressed secretions of duodenal juice, bilirubin and amylase, and raised bicarbonate concentration. But in our experiments, infusions of glucose and amino-acid solutions did not definitely elevate the level of bicarbonate con centration. Nakajima and Magee (1970) , studying effects of hypertonic glucose infusion on pancreatic exocrine secretion, noted the elevation in blood sugar level inversely related to a decreased secretion of pancreatic enzymes, particularly amylase. Our results also showed that the infusions of 20% glucose and 30% glucose solutions elevated blood sugar levels to average values of 261 mg/100 ml and 367 mg/100 ml, respectively. Although there was no significant difference in pancreatic juice volume as the effects of loading with 20% and 30% glucose, the observed levels of amylase output indicated that the inhibitory effect of the infusions on this enzyme secretion was greater with 30% glucose than with 20% glucose. The results fairly agree with those of Nakajima and Magee. On the other hand, Hebb (1935) noted that a glucose-infusion-induced high level of blood sugar led to an elevation in concentration of enzymes in pancreatic juice; but finding that such effect was impeded by the intervention of atropine, they postulated the existence of some mechanisms that might act with nervous stimulation, even tually causing such a phenomenon. In the present experiments, the infusions of 20% glucose and 30% glucose solutions both tended to extend suppressive effects comparatively greater on amylase output than on pancreatic juice secretion as a whole. This shows that glucose infusion elevated amylase concentration. increased sharply from its reduced bottom of 47% to 74% at the end of 20 min. With glucagon loading, the levels of blood sugar progressively dropped with increases in dose, but increased with time after administration (Table 1 ). This can be followed by the concept that glycogen stored in the liver decreased by repeated injections of glucagon, subduing a rise in blood sugar level. As a basic mechanism of the suppression of pancreatic exocrine secretion due to glucagon, the competitive inhibition is more largely supported than the decreased visceral blood flow. Konturek et al. (1974) found that there was a competitive inhibition between pancreozymm and glucagon. Case et al. (1972) , found that the infusion of pancreozymin, similarly to that of glucagon, induced increases in intracellular cyclic AMP and secretion of enzymes and suspected that the two substances may hold the same receptor. Secretion of glucagon in the body is promoted in hypoglycemia and hyperamino acidemia or by administration of pancreozymin. Ohneda et al. (1968) reported that the level of glcuagon rose from 1.1 mg/100 ml to 2.7 mg/100 ml with infusion of amino acids, while it slightly lowered with infusion of glucose (Ohneda et al. 1969 ). According to their findings, glucagon seems to have no relation to the suppression of pancreatic exocrine secretion by administration of glucose.
The distribution of glucagon in the body is generally sparse in the peripheral vein compared to the portal vein, and it is known to be difficult to pursue changes with hours in the concentration of glucagon in the peripheral blood (Blackard et al. 1974) . Because of the technical failure encountered in conscious dogs we used anesthetized dogs and, infusing solutions of 20% glucose, 30% glucose and 12% amino acids under secretin and pancreozymin stimulation, sampled portal blood to determine IRG. As shown in Fig. 12 , glucagon secretion was evident with the infusion of 12% amino acids, but not with either 20% glucose or 30% glucose. Although there is a report showing a possible glucose stimulation of glucagon secretion during calcium deprivation (Meyer et al. 1975) , in most cases it is known that glucose loading tends to suppress glucagon secretion, so that it is improbable that glucagon can influence the suppression of pancreatic exocrine secretion with glucose infusion. But, with amino-acid infusion, the stimulated glucagon is considered contributing to suppressing pancreatic exocrine secretion.
Among various amino acids, when infused, asparatic acid is shown to act most positively to promote secretion of glucagon, followed by glycine and phenylanine, whereas leucine and isoleucine rather play a suppressive role (Rocha et al. 1972) . The combination of our 12% amino acids contained 18 varieties and had proved the strongest and most persistent of various combinations in the suppression of pancreatic exocrine secretion in conscious dogs. The suppressive effect on pancreatic exocrine function observed with infusion of amino acids appears to have been influenced by way of the secretion of glucagon.
From the clinical point of view, in scrutinizing indications for hyperalimenta tion in cases of acute pancreatitis, the most important step first to be taken will be to clarify the pancreatic endocrine status of the patient just after the onset of symptoms. Concerning the behavior and mechanism of pancreatic hormones at the time of acute pancreatitis , opinion differs with different authors. Satake et al. (1973) reported that in acute pancreatitis in dogs , blood insulin levels were precipitately elevated at the end of 30 min after the onest of symptoms along with the values of blood sugar, and , though the levels gradually declined thereafter, they remained higher than before the onset of symptoms . The phenomenon, they explained, appeared to reflect the transfer of proinsulin into insulin as a result of enzymolysis at acute pancreatitis. Paloyan et al. (1966) found the blood level of glucagon rising at acute pancreatitis in dogs. Knight et al. (1971 Knight et al. ( , 1972 hold a view that the elevation in glucagon level at aucte pancreatitis reflects a protective action of the body, and advocate favorable use of glucagon administration in acute pancreatitis. Amelioration of clinical symptoms of pancreatitis as a result of glucagon administration was also recognzied by Fleischer and Kasper (1974) . All these authors seem to support the elevation in glucagon level at acute pancreatitis unassociated with aggravation of the symptoms. On the other hand, Condon et al.
(1974) experimentally pointed out that glucagon treatment produced no favorable effect on remission of pancreatitis, rather disclosing an adverse effect with increased bleeding tendency. Thus, there is no consistent view as yet regarding glucagon administration in acute pancreatitis. CONCLUSION 1) Infusions of 20% glucose, 30% glucose and 12% amino acids at a rate of 200 ml/hr for 1 hr led to decreases in both the volume of pancreatic juice and amylase output. The decreases expressed as percentage to the initial level were 47% and 58% with 12% amino acids, 68% and 71% with 30% glucose, and 77% and 89% with 20% glucose, respectively. No changes were encountered in bicarbonate concentration.
2) The infusion of 20% mannitol at 200 ml/hr for 1 hr caused the volume of pancreatic juice to drop to 81% and amylase output to 64% at maximum, but at 50 min both reverted to intact levels despite the continuing infusion.
3) The infusion 12% amino acids at a rate of 200 ml/hr for 2 hr kept both pancreatic juice secretion and amylase output under suppression throughout the time, but produced no changes in bicarbonate concentration.
4) The injection of a modicum of glucagon at an interval of 50 min produced a transitory inhibition of pancreatic juice secretion and amylase excretion, the reduced values both tending to return to the initial level 30 min after each injec tion. No changes in bicarbonate concentration could be observed. 5) IRG in portal blood elevated its level with the infusion of 12% amino acids, but not with 20% glucose or 30% glucose (anesthetized dogs). 6) IRI in peripheral vein blood elevated its level with infusions of 12% amino acids, 20% glucose and 30% glucose.
